title: Angiotensin-converting enzyme inhibitors and beta-blockers in cardiac asymptomatic patients with Duchenne muscular dystrophy.
abstract: Duchenne muscular dystrophy (DMD) is an X-linkedrecessive disorder caused by the absence of dystrophin. Cardiac dysfunction is a classical complication in this disease. Most DMD patients remain asymptomatic for years in spite of the progression of cardiac dysfunction because of their limited daily activities. Angiotensin-converting enzyme inhibitors and beta-blockers may delay the onset and the progression of cardiac dysfunction and have to be recommended earlier in this disease.
authors.affiliation: Raymond Poincare Hospital, Critical Care Medicine, Garches, France. fayssoil2000@yahoo.fr
authors.forename: A
authors.initials: A
authors.lastname: Fayssoil
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D006331:Heart Diseases / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D020388:Muscular Dystrophy, Duchenne / Q000150:complications*
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors